Leukaemia – 60 years of progress – its what we work for.
Filed in medical report, October 28, 2008, 11:22 amI have just returned from most engaging presentation being held at the Nowgen centre in Manchester, the meeting entitled Leukaemia 60 years of Progress was a look a the progress we have made in treating Leukaemia in the past 60 years and I found it a massive boost to my moral and why I was [...]
Adaptive Clinical Trial Designs
Filed in clinical, , 10:17 amThe days of simple clinical trials are numbered, recent history has shown a steady increase in the duration, complexity and overall cost, this has been exemplified by a continued decrease in the number of New Molecular Entities Being approved by the FDA over the past few years.
Clinical trials have increase in duration by approximately 10% [...]
Drug R&D Licensing Economy was US$340bn in 2007
Filed in licensing, report, October 14, 2008, 2:16 pmMost drug discovery and development companies rely on licensing to fund their technology development programmes, either directly or as an exit for investors. We have complied a report that represents an attempt to put a figure on the amount of money that is circulating in the drug discovery and development economy. (full report available see [...]
Saving the World at Work – Book Review
Filed in Book Review, Uncategorized, October 9, 2008, 11:32 amA new book by Tim Saunders is always a source of excitement for those who know of Tim and his work, and this one is no exception.
Tim has produced what can best be described as a prescription for corporate harmony with mankind and the planet. The books lays out what individuals within companies and corporations [...]
Paediatric Investigation Plans – New Regulations
Filed in regulatory, October 7, 2008, 10:15 amNew regulations have come into force relating to the development of drugs for Children, and these regulations will impact on every single drug development programme currently ongoing. It is critical that you know about these regulations and how to adapt to them.
Every product must have agreed a Paediatric Investigational Plan (PIP) with the EMEA (via [...]
